Compare Charles River Laboratories Intl. Inc (CRL) vs First Trust NASDAQ Clean Edge Green Energy Idx Fd (QCLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs First Trust NASDAQ Clean Edge Green Energy Idx Fd — how do they compare? Charles River Laboratories Intl. Inc trades at $225.52 (market cap $11.14B), while First Trust NASDAQ Clean Edge Green Energy Idx Fd trades at $53.62. The key difference: Charles River Laboratories Intl. Inc is trading nearer its 52-week high, First Trust NASDAQ Clean Edge Green Energy Idx Fd nearer its low. Which is the better fit depends on your goals.
| CRL | QCLN | |
|---|---|---|
Market Cap | $11.14B | — |
Sector | Health | Sector/Thematic |
52-Week High | $233.60 | $68.47 |
52-Week Low | $145.57 | $34.31 |
Enterprise Value | $14.00B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.
Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.
QCLN trades at $53.57, down 3.82% with bearish technical signals from moving averages. The clean energy ETF faces mixed sentiment as policy uncertainties from stalled US permits and China restrictions contrast with strong global investment trends. RSI levels suggest potential oversold conditions at 27.51, while ADX indicates strong bearish momentum. Support consolidates around $55 with resistance at $56-57.
The clean energy sector shows long-term growth potential amid energy security concerns and rising demand, but near-term headwinds from US policy uncertainty and supply chain costs create volatility. Investor sentiment remains cautious despite favorable industry tailwinds, requiring careful risk assessment of regulatory developments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About First Trust NASDAQ Clean Edge Green Energy Idx Fd
QCLN invests in U.S.-listed companies engaged in clean energy technologies. It focuses on solar power, wind, electric vehicles, and energy storage, with major holdings in firms like Tesla, ON Semiconductor, and Rivian.
Read more on QCLN →
